Medical treatment innovation: barriers and opportunities
Barriers to innovation in medicines and medicinal technology and the opportunities for improvement: a study by Deloitte and partners.
PDF, 3.49MB, 109 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com . Please tell us what format you need. It will help us if you say what assistive technology you use.
As part of its work to set out new pathways for development of medicines and medical technology, ultimately to give NHS patients quicker access, the Accelerated Access Review team commissioned Monitor Deloitte, CASMI and King’s Fund to conduct a study into the barriers to getting patients faster access to innovation. The report maps the existing innovation pathways for medicines, devices and diagnostics.
The findings will feed into the wide ranging evidence base that the Accelerated Access Review team are collecting and analysing to support the review’s Chair, Sir Hugh Taylor, as he develops his thinking.